UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 92

Sortiert nach

Defining distinct features of anti-MOG antibody associated central nervous system demyelination

Therapeutic Advances in Neurological Disorders, 2018-01, Vol.11, p.1756286418762083-1756286418762083

2018

Volltextzugriff (PDF)

Maraviroc and JC Virus–Associated Immune Reconstitution Inflammatory Syndrome

The New England journal of medicine, 2014-01, Vol.370 (5), p.486-488

2014

Volltextzugriff (PDF)

The neuroradiology of progressive multifocal leukoencephalopathy: a clinical trial perspective

Brain (London, England : 1878), 2022-04, Vol.145 (2), p.426-440

2022

Volltextzugriff (PDF)

Detailed Characterization of T Cell Receptor Repertoires in Multiple Sclerosis Brain Lesions

Frontiers in immunology, 2018-03, Vol.9, p.509-509

2018

Volltextzugriff (PDF)

Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in ‘pattern II multiple sclerosis’ and brain biopsy findings in a MOG-IgG-positive case

Multiple sclerosis, 2016-10, Vol.22 (12), p.1541-1549

2016

Volltextzugriff (PDF)

Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients

Journal of neuroinflammation, 2012-01, Vol.9 (1), p.14-14, Article 14

2012

Volltextzugriff (PDF)

Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosis

Neurology : neuroimmunology & neuroinflammation, 2016-10, Vol.3 (5), p.e257-e257

2016

Volltextzugriff (PDF)

Severe meningo-/encephalitis after daclizumab therapy for multiple sclerosis

Multiple sclerosis, 2019-10, Vol.25 (12), p.1618-1632

2019

Volltextzugriff (PDF)

Wallerian Degeneration: A Major Component of Early Axonal Pathology in Multiple Sclerosis

Brain pathology (Zurich, Switzerland), 2010-09, Vol.20 (5), p.976-985

2010

Volltextzugriff (PDF)

Increased interleukin-27 cytokine expression in the central nervous system of multiple sclerosis patients

Journal of neuroinflammation, 2017-07, Vol.14 (1), p.144-144, Article 144

2017

Volltextzugriff (PDF)

Immunological and pathological characterization of fatal rebound MS activity following natalizumab withdrawal

Multiple sclerosis, 2017-01, Vol.23 (1), p.72-81

2017

Volltextzugriff (PDF)

Antibody signatures in patients with histopathologically defined multiple sclerosis patterns

Acta neuropathologica, 2020-03, Vol.139 (3), p.547-564

2020

Volltextzugriff (PDF)

Myelinosome formation represents an early stage of oligodendrocyte damage in multiple sclerosis and its animal model

Nature communications, 2016-11, Vol.7 (1), p.13275-13275, Article 13275

2016

Volltextzugriff (PDF)

Neuromyelitis optica lesions may inform multiple sclerosis heterogeneity debate

Annals of neurology, 2012-09, Vol.72 (3), p.385-394

2012

Volltextzugriff (PDF)

Diagnostic utility of aquaporin-4 in the analysis of active demyelinating lesions

Neurology, 2015-01, Vol.84 (2), p.148

2015

Volltextzugriff (PDF)

Early loss of oligodendrocytes in human and experimental neuromyelitis optica lesions

Acta neuropathologica, 2014-04, Vol.127 (4), p.523-538

2014

Volltextzugriff (PDF)

ADEM-like presentation, anti-MOG antibodies, and MS pathology: TWO case reports

Neurology : neuroimmunology & neuroinflammation, 2017-05, Vol.4 (3), p.e335-e335

2017

Volltextzugriff (PDF)

Limited TCF7L2 expression in MS lesions

PloS one, 2013-08, Vol.8 (8), p.e72822-e72822

2013

Volltextzugriff (PDF)

Serum neurofilament light chains in progressive multiple sclerosis patients treated with repeated cycles of high-dose intravenous steroids

Free Neuropathology, 2023, Vol.4

2023

Volltextzugriff (PDF)

Case Report: A Case of Severe Clinical Deterioration in a Patient With Multiple Sclerosis

Frontiers in neurology, 2020-08, Vol.11, p.782-782

2020

Volltextzugriff (PDF)

Microsurgical fenestration of perineural cysts to the thecal sac at the level of the distal dural sleeve

Acta neurochirurgica, 2011-07, Vol.153 (7), p.1427-1434

2011

Volltextzugriff (PDF)

Serum peptide reactivities may distinguish neuromyelitis optica subgroups and multiple sclerosis

Neurology : neuroimmunology & neuroinflammation, 2016-04, Vol.3 (2), p.e204-e204

2016

Volltextzugriff (PDF)

Rebound After Fingolimod and a Single Daclizumab Injection in a Patient Retrospectively Diagnosed With NMO Spectrum Disorder-MRI Apparent Diffusion Coefficient Maps in Differential Diagnosis of Demyelinating CNS Disorders

Frontiers in neurology, 2018-09, Vol.9, p.782-782

2018

Volltextzugriff (PDF)

Long‐term clinical, imaging and cognitive outcomes association with MS immunopathology

Annals of clinical and translational neurology, 2023-03, Vol.10 (3), p.339-352

2023

Volltextzugriff (PDF)

Mitoxantrone treatment in a patient with multiple sclerosis and pattern III lesions

Clinical & experimental neuroimmunology, 2018-08, Vol.9 (3), p.169-172

2018

Volltextzugriff (PDF)

1 – 25 von 92

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(85)
Mit Volltextzugriff
(84)

Publikationsform

Artikel
(87)
Berichte
(5)

Sprache

Englisch
(90)
Japanisch
(19)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Defining distinct features of anti-MOG antibody associated central nervous system demyelination

Maraviroc and JC Virus–Associated Immune Reconstitution Inflammatory Syndrome

The neuroradiology of progressive multifocal leukoencephalopathy: a clinical trial perspective

Detailed Characterization of T Cell Receptor Repertoires in Multiple Sclerosis Brain Lesions

Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in ‘pattern II multiple sclerosis’ and brain biopsy findings in a MOG-IgG-positive case

Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients

Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosis

Severe meningo-/encephalitis after daclizumab therapy for multiple sclerosis

Wallerian Degeneration: A Major Component of Early Axonal Pathology in Multiple Sclerosis

Increased interleukin-27 cytokine expression in the central nervous system of multiple sclerosis patients

Immunological and pathological characterization of fatal rebound MS activity following natalizumab withdrawal

Antibody signatures in patients with histopathologically defined multiple sclerosis patterns

Myelinosome formation represents an early stage of oligodendrocyte damage in multiple sclerosis and its animal model

Neuromyelitis optica lesions may inform multiple sclerosis heterogeneity debate

Diagnostic utility of aquaporin-4 in the analysis of active demyelinating lesions

Early loss of oligodendrocytes in human and experimental neuromyelitis optica lesions

ADEM-like presentation, anti-MOG antibodies, and MS pathology: TWO case reports

Limited TCF7L2 expression in MS lesions

Serum neurofilament light chains in progressive multiple sclerosis patients treated with repeated cycles of high-dose intravenous steroids

Case Report: A Case of Severe Clinical Deterioration in a Patient With Multiple Sclerosis

Microsurgical fenestration of perineural cysts to the thecal sac at the level of the distal dural sleeve

Serum peptide reactivities may distinguish neuromyelitis optica subgroups and multiple sclerosis

Rebound After Fingolimod and a Single Daclizumab Injection in a Patient Retrospectively Diagnosed With NMO Spectrum Disorder-MRI Apparent Diffusion Coefficient Maps in Differential Diagnosis of Demyelinating CNS Disorders

Long‐term clinical, imaging and cognitive outcomes association with MS immunopathology

Mitoxantrone treatment in a patient with multiple sclerosis and pattern III lesions

Suchergebnisse filtern